Get a behind the scenes look into the recent filming of our Patient Service Announcement with #NASH / #MASH patient and advocate, Terri. We enjoyed hearing the reasons this PSA is so important to her. Stay tuned for the video!
Madrigal Pharmaceuticals
Pharmaceutical Manufacturing
Conshohocken, Pennsylvania 45,564 followers
Madrigal is focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases.
About us
Madrigal (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. For more information, visit www.madrigalpharma.com.
- Website
-
https://www.madrigalpharma.com/
External link for Madrigal Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Conshohocken, Pennsylvania
- Type
- Public Company
- Founded
- 2016
- Specialties
- Liver Disease, NASH, Metabolic Disease, and MASH
Locations
-
Primary
200 Barr-Harbor Dr
Suite 200
Conshohocken, Pennsylvania 19428, US
Employees at Madrigal Pharmaceuticals
Updates
-
Today, we announced the appointment of Michael Charlton MBBS, FRCP as Senior Vice President, Clinical Development. We are thrilled to welcome Dr. Charlton as we shape the next phase of our R&D strategy. Read more: https://lnkd.in/evGuN_p4
-
Press Release: Read the latest news about Madrigal’s clinical research in NASH/MASH: https://lnkd.in/eykMd-6r
-
We believe that diversity, equity, and inclusion are the cornerstones of a thriving workplace. This #HispanicHeritageMonth, we are honored to share the story of Priscilla Razi, whose unique experiences and perspectives help us make an impact within the Hispanic community. NASH kNOWledge
-
As we celebrate Bill Sibold’s one-year anniversary as CEO at Madrigal, we’re proud to highlight the remarkable progress we’ve achieved in the last year. Bill’s guidance and leadership have been instrumental during this exciting period of growth, and we look forward to the opportunities ahead. Hear why it’s a dynamic time to join the Madrigal team, and explore current job openings: https://lnkd.in/eH9syce8
Explore Current Job Openings
-
#HispanicHeritageMonth is an important opportunity to raise awareness about #NASH / #MASH in the Latino community. NASH kNOWledge has many Spanish-language resources, including a website: https://higadograso.org/. Follow NASH kNOWledge on social media to learn more! Madrigal is proud to provide patient advocacy grants to help support outreach to the Latino community.
-
People living with #NASH / #MASH have historically felt unclear about a path to managing care. Kristin Bucklen, Vice President of Patient Marketing, elaborates on our approach to empowering individuals living with NASH/MASH to find a ‘way forward’ through education and engagement in a recent interview with Fierce Pharma: https://lnkd.in/eb6ygc4e
-
Join us for an engaging Product Theater at the Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) Seventh Annual Conference with speakers Ann Moore, FNP-C, Arizona Liver Health, and Jonathan 葉景湞 Yeh, PA, MBA, Columbia University Irving Medical Center, on September 12. View more details below.
-
We’re thrilled to celebrate a significant milestone at Madrigal, where more than 300 colleagues have joined us so far in 2024. Eight employees in 2016 has now grown to 500 team members! Welcome Khyati Oza Gosalia, our 500th colleague and a trained scientist with experience in project and alliance management. Khyati has lived as an expat in Korea and Vietnam and enjoys learning about different cultures, cooking, and spending time with her family and Australian labradoodle. She joins our expanding team of talented individuals, all dedicated to improving care for patients with NASH/MASH. Check out the Careers page to see our current openings: https://lnkd.in/eH9syce8